Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Jeremy D, Rubinstein"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Inotuzumab ozogamicin (InO) is an antibody drug conjugate composed of a humanized monoclonal antibody targeting the cell surface receptor CD22 coupled to a cytotoxic calicheamicin payload via an acid labile linker. InO has shown significant activity
Externí odkaz:
https://doaj.org/article/44c714fac20948a5b4c501e9e91d53d8
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 521-525 (2022)
Abstract SRP54 mutations have recently been implicated in congenital neutropenia (CN) and the in‐frame deletion, p.Thr117del, is the most common pathogenic mutation reported. The largest study of SRP54‐mutated CN to‐date followed 23 patients fo
Externí odkaz:
https://doaj.org/article/43aa27e7f5854a5285d94d3d10701344
Autor:
Thomas J. Galletta, Adam Lane, Carolyn Lutzko, Thomas Leemhuis, Jose A. Cancelas, Ruby Khoury, YunZu M. Wang, Patrick J. Hanley, Michael D. Keller, Catherine M. Bollard, Stella M. Davies, Michael S. Grimley, Jeremy D. Rubinstein
Publikováno v:
Transplantation and Cellular Therapy. 29:305-310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aae0c615a7093ae5ed6e821e26b2e495
https://doi.org/10.1016/j.jtct.2023.01.027
https://doi.org/10.1016/j.jtct.2023.01.027
Autor:
Zeinab A. M. Afify, Mary M. Taj, Manuela Orjuela‐Grimm, Kavitha Srivatsa, Tamara P. Miller, Holly J. Edington, Mansi Dalal, Joanna Robles, James B. Ford, Matthew J. Ehrhardt, Tonya J. Ureda, Jeremy D. Rubinstein, Sarah McCormack, Julie M. Rivers, Karen M. Chisholm, Madison K. Kavanaugh, Andrew J. Bukowinski, Erika D. Friehling, Maegan C. Ford, Sonika N. Reddy, Lianna J. Marks, Christine Moore Smith, Clinton C. Mason
Publikováno v:
Cancer. 129:780-789
Pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorder [EBV(-)M-PTLD] comprises approximately 10% of M-PTLD. No large multi-institutional pediatric-specific reports on treatment and outcome are avai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd0dacd4474ae357d6f5c6a851f75807
https://doi.org/10.1002/cncr.34600
https://doi.org/10.1002/cncr.34600
Autor:
Thomas J. Galletta, Jeremy D. Rubinstein, Christa Krupski, Adam S. Nelson, Ruby Khoury, Christopher E. Dandoy, Stella M. Davies, Christine L. Phillips
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57e77690fb44e2366af145be42559e52
https://doi.org/10.1002/pbc.30271
https://doi.org/10.1002/pbc.30271
Autor:
Jonathan D. Bender, Jeremy D. Rubinstein, Benjamin Mizukawa, John P. Perentesis, Lauren Pommert
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a87067f21d9ad0cf123a1427a0a6f27e
https://doi.org/10.1002/pbc.30214
https://doi.org/10.1002/pbc.30214
Autor:
Valeria Ceolin, Erica Brivio, Harm van Tinteren, Susan R. Rheingold, Allison Leahy, Britta Vormoor, Maureen M. O’Brien, Jeremy D. Rubinstein, Krzysztof Kalwak, Barbara De Moerloose, Elad Jacoby, Peter Bader, Mónica López-Duarte, Bianca F. Goemans, Franco Locatelli, Peter Hoogerbrugge, Friso G. Calkoen, Christian Michel Zwaan
Publikováno v:
Leukemia, 37(1), 53-60. Nature Publishing Group
Chimeric antigen receptor T cells targeting CD19 (CART-19) have shown remarkable efficacy for relapsed/refractory (R/R) B-cell precursor acute lymphoblastic leukemia (BCP-ALL). We investigated whether prior use of inotuzumab ozogamicin (InO), an anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdb2558dcf01a3d2509ef946f2f279a
https://pure.eur.nl/en/publications/b1d78fd8-f55c-4bad-9cb7-ee581fb6ab64
https://pure.eur.nl/en/publications/b1d78fd8-f55c-4bad-9cb7-ee581fb6ab64
Autor:
Thomas Leemhuis, Lorraine Ray, Stella M. Davies, Diana Clark, Adam S. Nelson, Sonata Jodele, Sana Emberesh, Olivia Grimley, Alessandro Sette, Carolyn Lutzko, Catherine M. Bollard, Shawn Thomas, Cecilia S. Lindestam Arlehamn, Giang Pham, Jose A. Cancelas, Patrick J. Hanley, Jeremy D. Rubinstein, Michael Grimley, Michael D. Keller, Xiang Zhu, Teri Clark
Publikováno v:
Blood Adv
Infection with adenoviruses is a common and significant complication in pediatric patients after allogeneic hematopoietic stem cell transplantation. Treatment options with traditional antivirals are limited by poor efficacy and significant toxicities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c7505aed7653c54d9b0689e18622e96
https://doi.org/10.1182/bloodadvances.2021004456
https://doi.org/10.1182/bloodadvances.2021004456
Autor:
Jeremy D. Rubinstein, Erin H. Breese, M. Christa Krupski, Maureen M. O'Brien, Christopher E. Dandoy, Ben Mizukawa, Ruby Khoury, Robin E. Norris, Stella M. Davies, Christine L. Phillips
Publikováno v:
Transplantation and Cellular Therapy. 29:311.e1-311.e7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::57cebc078039eeb64b93f3112b0e7903
https://doi.org/10.1016/j.jtct.2023.02.012
https://doi.org/10.1016/j.jtct.2023.02.012
Autor:
Adam S. Nelson, Christine L Phillips, Jeremy D. Rubinstein, Stella M. Davies, Maureen M. O'Brien, Christa Krupski
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:e280-e285
Autologous CD19-directed chimeric antigen receptor T lymphocyte (CAR-T) therapy is an approved and effective treatment for the management of patients with refractory and multiply relapsed B cell precursor acute lymphoblastic leukemia (B-ALL). Experie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5da0d7c02bd850085c56a27f733c5769
https://doi.org/10.1016/j.bbmt.2020.07.036
https://doi.org/10.1016/j.bbmt.2020.07.036